Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (111-120 of 349) with videos related to

Pageof 35
Sort By:
Journal of Diabetes and Its Complications|June 25, 2017
Re: Subclinical thyroid dysfunction and mortality in type 2 diabetesImran Badshah, S A Paul Chubb, Wendy A Davis, et al.
Journal of the Endocrine Society|April 30, 2025
Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2Wendy A Davis, Aron Chakera, S A Paul Chubb, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 20, 2022
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase IIJocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, et al.
Journal of Diabetes and Its Complications|August 23, 2005
Community-acquired infections in type 2 diabetic patients and their nondiabetic partners. The Fremantle Diabetes StudyTimothy M E Davis, Thilak Weerarathne, Yvonne Foong, et al.
Diabetes & Vascular Disease Research|July 30, 2010
Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Diabetes Care|May 22, 2019
Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109Wendy A Davis, Emma J Hamilton, David G Bruce, et al.
Journal of Clinical Medicine|October 13, 2021
Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Database of AustraliaNishant Nundlall, David Playford, Geoff Strange, et al.
Atherosclerosis|September 15, 2010
Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes StudyKatrin Schimke, Stephen A P Chubb, Wendy A Davis, et al.
Diabetes Care|November 21, 2018
Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase IWendy A Davis, Emma J Hamilton, David G Bruce, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Pageof 35

Showing results (111-120 of 349) with videos related to

Sort By:
Pageof 35
Journal of Diabetes and Its Complications|June 25, 2017
Re: Subclinical thyroid dysfunction and mortality in type 2 diabetesImran Badshah, S A Paul Chubb, Wendy A Davis, et al.
Journal of the Endocrine Society|April 30, 2025
Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2Wendy A Davis, Aron Chakera, S A Paul Chubb, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 20, 2022
Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase IIJocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, et al.
Journal of Diabetes and Its Complications|August 23, 2005
Community-acquired infections in type 2 diabetic patients and their nondiabetic partners. The Fremantle Diabetes StudyTimothy M E Davis, Thilak Weerarathne, Yvonne Foong, et al.
Diabetes & Vascular Disease Research|July 30, 2010
Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Diabetes Care|May 22, 2019
Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102-109Wendy A Davis, Emma J Hamilton, David G Bruce, et al.
Journal of Clinical Medicine|October 13, 2021
Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Database of AustraliaNishant Nundlall, David Playford, Geoff Strange, et al.
Atherosclerosis|September 15, 2010
Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes StudyKatrin Schimke, Stephen A P Chubb, Wendy A Davis, et al.
Diabetes Care|November 21, 2018
Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase IWendy A Davis, Emma J Hamilton, David G Bruce, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Pageof 35